Wird geladen...

CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment

Despite the development of targeted therapies and novel inhibitors, cancer remains an undefeated disease. Resistance mechanisms arise quickly and alternative treatment options are urgently required, which may be partially met by drug combinations. Protein kinases as signaling switchboards are freque...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceuticals (Basel)
Hauptverfasser: Scheiblecker, Lisa, Kollmann, Karoline, Sexl, Veronika
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2020
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7760252/
https://ncbi.nlm.nih.gov/pubmed/33255177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph13120418
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!